Correlation Between Neurocrine Biosciences and 655844CJ5
Specify exactly 2 symbols:
By analyzing existing cross correlation between Neurocrine Biosciences and NSC 41 15 MAY 21, you can compare the effects of market volatilities on Neurocrine Biosciences and 655844CJ5 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of 655844CJ5. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and 655844CJ5.
Diversification Opportunities for Neurocrine Biosciences and 655844CJ5
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Neurocrine and 655844CJ5 is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and NSC 41 15 MAY 21 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NSC 41 15 and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with 655844CJ5. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NSC 41 15 has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and 655844CJ5 go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and 655844CJ5
Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 0.75 times more return on investment than 655844CJ5. However, Neurocrine Biosciences is 1.33 times less risky than 655844CJ5. It trades about 0.22 of its potential returns per unit of risk. NSC 41 15 MAY 21 is currently generating about -0.17 per unit of risk. If you would invest 12,711 in Neurocrine Biosciences on September 24, 2024 and sell it today you would earn a total of 831.00 from holding Neurocrine Biosciences or generate 6.54% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 85.0% |
Values | Daily Returns |
Neurocrine Biosciences vs. NSC 41 15 MAY 21
Performance |
Timeline |
Neurocrine Biosciences |
NSC 41 15 |
Neurocrine Biosciences and 655844CJ5 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neurocrine Biosciences and 655844CJ5
The main advantage of trading using opposite Neurocrine Biosciences and 655844CJ5 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, 655844CJ5 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 655844CJ5 will offset losses from the drop in 655844CJ5's long position.Neurocrine Biosciences vs. Fate Therapeutics | Neurocrine Biosciences vs. Sana Biotechnology | Neurocrine Biosciences vs. Caribou Biosciences | Neurocrine Biosciences vs. Arcus Biosciences |
655844CJ5 vs. Cheniere Energy Partners | 655844CJ5 vs. Enel Chile SA | 655844CJ5 vs. Eastman Kodak Co | 655844CJ5 vs. Transportadora de Gas |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |